MAIA Biotechnology, Inc. Adjustments to Additional Paid in Capital, Warrant Issued
MAIA Biotechnology, Inc. (MAIA) reported Adjustments to Additional Paid in Capital, Warrant Issued of $4.11 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-23.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-08-10
- MAIA Biotechnology, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2025-06-30 was $762.84K.
- MAIA Biotechnology, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2025-03-31 was $1.68M.
- MAIA Biotechnology, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2025 was $4.11M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|
| 2025-12-31 | $4.11M 10-K · filed 2026-03-23 | ||
| 2025-06-30 | $762.84K 10-Q · filed 2026-08-10 | $2.44M derived: sum of 2 quarters · filed 2026-08-10 | |
| 2025-03-31 | $1.68M 10-Q · filed 2026-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |